INSIDE

evismo in the final of the Swiss Medtech Award 2025

March 2025, evismo is nominated as a finalist for the Swiss Medtech Award 2025 and competes against Bonebridge and QUMEA. The award recognises innovation and excellence in Swiss medical technology Read the article

Argomed deFACTO: diagnose sleep apnea directly in your  general practitioner's office

March 2025, With CardioFlex evismo brought cardiology into your general practitioner’s office. Now, with RespiFlex, sleep specialists are ready to diagnose your sleep apnea – without long waiting times. And what does the specialist say about evismo RespiFlex? Read the article

Handelszeitung: evismo verspricht schnellere und präzisere Diagnosen

Januar 2025, In einem Artikel in der Handelszeitung sowie in einem Podcast-Interview gibt unsere Co-CEO Willemien van den Toorn Einblicke in die Mission, Vision und Erfolge von evismo.  Read the article

«Die HRV hat sich als wertvolles Instrument zur Messung und Diagnose von Stress und Burnout etabliert.»

November 2024, Im Interview erklärt Dr. med. Claude Sidler, StressChec-Spezialist und Arbeitsmediziner, weshalb die HRV-Diagnose wie Fieber messen in der Hausarztpraxis ist.  Zum Interview

«Der CardioFlex-Sensor ist sehr klein und kaum bemerkbar. Besonders wichtig ist für alle, dass sie damit duschen können.»

September 2024, Im Interview zur Anwendung von CardioFlex in der Klinik Gut in St. Moritz berichtet MPA Alissa Gmür von den Vorteilen für die Patienten und die Klinik.   Zum Interview

Lunch-Webinar evismo StressCheck (only in German)

2. July 2024, Get to know the evismo StressCheck and diagnose stress, burnout and sleep disorders directly in your practice  To the Lunch-Webinar

Detect cardiac arrhythmia using longer ECG measurements

August 2024, Recognising and treating cardiac arrhythmia at an early stage can save lives. That's what the specialists say. To the blog

SIHLMED relies on the evismo StressCheck for HRV analysis

May 2024, SIHLMED, the Centre for Integrative Medicine in Zurich, has been using evismo's StressCheck for its patients since March 2024. To the blog

evismo receives the Innosuisse Certificate

February 2024, evismo receives Innosuisse certificate and thus confirms 'readiness' for sustainable growth.To the blog

evismo CardioFlex in the SRF health magazine Puls

January 2024, With CardioFlex, the heart rhythm and heart rate are measured when energy drinks are consumed and analysed by a specialist.  To the article

 Interview with Dr. med. Eva Schibli-Kaspar, DoktorHaus Fislisbach

November 2023, DoktorHaus Fislisbach has been using the Cardioflex long-term ECG service from evismo for around three years. Dr med. Eva. Schibli-Kaspar explains why in an interview. To the interview

Interview with the MPAs of GMPP

August 2023, We would like to use interviews to ensure an exchange of experiences among our customers. We are pleased to learn more about how GMPP's MPAs use CardioFlex.  To the interview

Interview with Bernd Eigenberger, MD, Deputy Head of Medical Center Medbase Kreuzlingen

April 2023, Mittels Interviews mit Hausärzten, Kardiologinnen und medizinischen Praxisassistentinnen möchten wir den Erfahrungsaustausch unter unseren Kundinnen und Kunden gewährleisten, um gemeinsam das Patientenerlebnis zu optimieren und die diagnostische Ausbeute zu erhöhen.  Zum Interview

Interview with Michel Wenger, Medical Director of Centramed

April 2023, by conducting interviews with GPs, cardiologists and medical practice assistants, we want to ensure an exchange of experiences among our customers in order to jointly optimise the patient experience and increase the diagnostic yield. To the interview

Podcast on Diagnostics-as-a-Service and vital signs monitoring

November 2022, Willemien van den Toorn, Co-Founder evismo, explains in the Health Terminal Podcast what Diagnostics-as-a-Service is and how they enable ambulatory vital signs monitoring with evismo. To the podcast

EHRA recommends AF screening

October 2022, the European Heart Rhythm Association (EHRA) recommends a broad approach to screening for atrial fibrillation for early detection of cardiac arrhythmias DE / FR / EN

evismo wins innovation prize

October 2022, evismo has participated in the public 'Call for Idea Funding' of the NTN Innovation Booster of Innosuisse. For the submitted project 'Smart Framework for Vital Sign Monitoring' evismo has won the innovation prize endowed with 20'000 Swiss Francs. The capital will be used to further optimize patient comfort and the quality of data transmission when wearing digital sensors. To the Innovation Booster

Three feature articles for the IFAS 

October 2022, For the IFAS-Expo 2022 we published three feature articles:

• Our long-term ECG service CardioFlex ( DE / FR /EN
• The widespread disease atrial fibrillation ( DE / FR / EN
• Our vision for Diagnostics-as-a-Service ( DE / FR / EN
  
  

Cost guarantees for long-term ECG obsolete

September 2022, The tariff commission of the Swiss Society of Cardiology has released new rate recommendations for long-term ECGs  DE / FR

New EHRA Guide

August 2022, the European Heart Rhythm Association (EHRA) recommends ECG-based devices as CardioFlex for early detection of cardiac arrhythmias DE / FR / EN

Innosuisse supports evismo

31. May, 2022, Innosuisse supports the development of algorithms for early detection and prediction of cardiac arrhythmias DE / FR / EN

Financing round of 1 million CHF

14. September, 2021,  evismo schliesst Finanzierungsrunde über 1 Million CHF für die Skalierung ab DE / FR / EN